ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
Key Highlights
- ➤Q3 2026 results scheduled for October 28 after market close
- ➤Investor conference call set for 4:30 p.m. Eastern on October 28
- ➤ClearPoint Neuro Navigation System has FDA clearance and CE marking
- ➤Company warns results may differ materially from forward-looking statements
Expert Statements
Danilo D'Alessandro, Chief Financial Officer of ClearPoint Neuro
“Investor Relations”
SOLANA BEACH, CA / ACCESS Newswire / October 14, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2026 third quarter on Wednesday, October 28, 2026, after the market close.
Investors and analysts are invited to listen to the live broadcast review of the Company's 2026 third quarter on Wednesday, October 28 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) which may be accessed online here. Investors and analysts who would like to participate in the conference call via telephone may do so at (877) 407-9034, or at (201) 493-6737 if calling from outside the U.S. or Canada.
Get started
Create a free account to read the full story.